Terms: = Astrocytoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
389 results:
1. A syngeneic spontaneous zebrafish model of
Weiss A; D'Amata C; Pearson BJ; Hayes MN
Elife; 2024 Jul; 13():. PubMed ID: 39052000
[TBL] [Abstract] [Full Text] [Related]
2. The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis.
Shi Y; Kang X; Ge Y; Cao Y; Li Y; Guo X; Chen W; Guo S; Wang Y; Liu D; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Feng F; Wang Y; You H; Ma W
BMC Neurol; 2024 Jun; 24(1):202. PubMed ID: 38877400
[TBL] [Abstract] [Full Text] [Related]
3. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.
Azimi P; Yazdanian T; Ahmadiani A
BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447
[TBL] [Abstract] [Full Text] [Related]
4. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract] [Full Text] [Related]
5. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
6. Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes.
Guyon J; Haidar Ahmad S; El Baba R; Le Quang M; Bikfalvi A; Daubon T; Herbein G
Cancer Gene Ther; 2024 Jul; 31(7):1070-1080. PubMed ID: 38553638
[TBL] [Abstract] [Full Text] [Related]
7. N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
Pagano C; Coppola L; Navarra G; Avilia G; Savarese B; Torelli G; Bruzzaniti S; Piemonte E; Galgani M; Laezza C; Bifulco M
FEBS Open Bio; 2024 May; 14(5):843-854. PubMed ID: 38514913
[TBL] [Abstract] [Full Text] [Related]
8. Integrative multi-omics characterization reveals sex differences in glioblastoma.
Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
[TBL] [Abstract] [Full Text] [Related]
9. Genetic mutation patterns among glioblastoma patients in the Taiwanese population - insights from a single institution retrospective study.
Huang YF; Chiao MT; Hsiao TH; Zhan YX; Chen TY; Lee CH; Liu SY; Liao CH; Cheng WY; Yen CM; Lai CM; Chen JP; Shen CC; Yang MY
Cancer Gene Ther; 2024 Jun; 31(6):894-903. PubMed ID: 38418842
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
Ge W; Yuan G; Wang D; Dong L
Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
[TBL] [Abstract] [Full Text] [Related]
11. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract] [Full Text] [Related]
12. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Spiekman IAC; Geurts BS; Zeverijn LJ; de Wit GF; van der Noort V; Roepman P; de Leng WWJ; Jansen AML; Kusters B; Beerepoot LV; de Vos FYFL; de Groot DA; de Groot JWB; Hoeben A; Buter J; Gelderblom HAJ; Voest EE; Verheul HMW
Oncologist; 2024 May; 29(5):431-440. PubMed ID: 38109296
[TBL] [Abstract] [Full Text] [Related]
14. Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations.
Dabkowski TR; Varkhedi M; Song JJ; Gozlan EC; Blanck G
JCO Precis Oncol; 2023 Sep; 7():e2300057. PubMed ID: 38085056
[TBL] [Abstract] [Full Text] [Related]
15. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.
Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
[TBL] [Abstract] [Full Text] [Related]
16. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.
Molica C; Gili A; Nardelli C; Pierini T; Arniani S; Beacci D; Mavridou E; Mandarano M; Corinaldesi R; Metro G; Gorello P; Giovenali P; Cenci N; Castrioto C; Lupattelli M; Roila F; Mecucci C; La Starza R
Sci Rep; 2023 Nov; 13(1):20101. PubMed ID: 37973912
[TBL] [Abstract] [Full Text] [Related]
17. Comparative Analysis of the Prognostic Significance of IDH,TERT, egfr and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
[TBL] [Abstract] [Full Text] [Related]
18. Epigenomic perturbation of novel egfr enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide.
Vincent CA; Nissen I; Dakhel S; Hörnblad A; Remeseiro S
BMC Cancer; 2023 Oct; 23(1):945. PubMed ID: 37803333
[TBL] [Abstract] [Full Text] [Related]
19. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
Furuta T; Negoto T; Miyoshi H; Moritsubo M; Nakamura H; Morioka M; Akiba J; Ohshima K; Sugita Y
J Neurooncol; 2023 Sep; 164(3):633-641. PubMed ID: 37710025
[TBL] [Abstract] [Full Text] [Related]
20. Tumor-associated monocytes promote mesenchymal transformation through egfr signaling in glioma.
Chen Y; Huo R; Kang W; Liu Y; Zhao Z; Fu W; Ma R; Zhang X; Tang J; Zhu Z; Lyu Q; Huang Y; Yan M; Jiang B; Chai R; Bao Z; Hu Z; Wang W; Jiang T; Cao Y; Wang J
Cell Rep Med; 2023 Sep; 4(9):101177. PubMed ID: 37652019
[TBL] [Abstract] [Full Text] [Related]
[Next]
